Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.

The market is mainly driven by the significant applications of Opioids Agonist Drugs in various end use industries. The expanding demands from the Pain Management, Cough Treatment and Diarrhea Treatment,, are propelling Opioids Agonist Drugs market. Codeine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fentanyl segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Opioids Agonist Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Opioids Agonist Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Opioids Agonist Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Opioids Agonist Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Opioids Agonist Drugs covered in this report include Purdue Pharma, Titan pharmaceuticals, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc, Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Egalet Corporation and Endo Pharmaceuticals Inc., etc.

The global Opioids Agonist Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Purdue Pharma

Titan pharmaceuticals

Boehringer Ingelheim

Janssen Pharmaceuticals, Inc

Sanofi

Sun Pharmaceuticals

Mallinckrodt Pharmaceuticals

Egalet Corporation

Endo Pharmaceuticals Inc.

Allergan, Plc

Pfizer Inc

Johnson & Johnson Services, Inc.

Hikma Pharmaceuticals PLC

Grünenthal

AbbVie Inc.

Scope of Opioids Agonist Drugs - Market Report

Report Metric	Details
Report Name	Opioids Agonist Drugs - Market
Forecasted market size in 2029	US$ 24650 million
CAGR	2.9%
Forecasted years	2023 - 2029
Global Opioids Agonist Drugs market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Opioids Agonist Drugs market, Segment by Type:	Codeine Fentanyl Meperidine Methadone Morphine Hydrocodone
Global Opioids Agonist Drugs market, by Application	Pain Management Cough Treatment Diarrhea Treatment
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Opioids Agonist Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Opioids Agonist Drugs - Market size in 2029?

Ans: The Opioids Agonist Drugs - Market size in 2029 will be US$ 24650 million.

What are the Application segmentation covered in the Opioids Agonist Drugs - Market report?

Ans: The Applications covered in the Opioids Agonist Drugs - Market report are Pain Management, Cough Treatment, Diarrhea Treatment

What are the Type segmentation covered in the Opioids Agonist Drugs - Market report?

Ans: The Types covered in the Opioids Agonist Drugs - Market report are Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone

1 Market Overview of Opioids Agonist Drugs

1.1 Opioids Agonist Drugs Market Overview

1.1.1 Opioids Agonist Drugs Product Scope

1.1.2 Opioids Agonist Drugs Market Status and Outlook

1.2 Global Opioids Agonist Drugs Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Opioids Agonist Drugs Market Size by Region (2018-2029)

1.4 Global Opioids Agonist Drugs Historic Market Size by Region (2018-2023)

1.5 Global Opioids Agonist Drugs Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Opioids Agonist Drugs Market Size (2018-2029)

1.6.1 North America Opioids Agonist Drugs Market Size (2018-2029)

1.6.2 Europe Opioids Agonist Drugs Market Size (2018-2029)

1.6.3 Asia-Pacific Opioids Agonist Drugs Market Size (2018-2029)

1.6.4 Latin America Opioids Agonist Drugs Market Size (2018-2029)

1.6.5 Middle East & Africa Opioids Agonist Drugs Market Size (2018-2029)

2 Opioids Agonist Drugs Market by Type

2.1 Introduction

2.1.1 Codeine

2.1.2 Fentanyl

2.1.3 Meperidine

2.1.4 Methadone

2.1.5 Morphine

2.1.6 Hydrocodone

2.2 Global Opioids Agonist Drugs Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Opioids Agonist Drugs Historic Market Size by Type (2018-2023)

2.2.2 Global Opioids Agonist Drugs Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Opioids Agonist Drugs Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Opioids Agonist Drugs Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Opioids Agonist Drugs Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Opioids Agonist Drugs Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Opioids Agonist Drugs Revenue Breakdown by Type (2018-2029)

3 Opioids Agonist Drugs Market Overview by Application

3.1 Introduction

3.1.1 Pain Management

3.1.2 Cough Treatment

3.1.3 Diarrhea Treatment

3.2 Global Opioids Agonist Drugs Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Opioids Agonist Drugs Historic Market Size by Application (2018-2023)

3.2.2 Global Opioids Agonist Drugs Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Opioids Agonist Drugs Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Opioids Agonist Drugs Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Opioids Agonist Drugs Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Opioids Agonist Drugs Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Opioids Agonist Drugs Revenue Breakdown by Application (2018-2029)

4 Opioids Agonist Drugs Competition Analysis by Players

4.1 Global Opioids Agonist Drugs Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2022)

4.3 Date of Key Players Enter into Opioids Agonist Drugs Market

4.4 Global Top Players Opioids Agonist Drugs Headquarters and Area Served

4.5 Key Players Opioids Agonist Drugs Product Solution and Service

4.6 Competitive Status

4.6.1 Opioids Agonist Drugs Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Purdue Pharma

5.1.1 Purdue Pharma Profile

5.1.2 Purdue Pharma Main Business

5.1.3 Purdue Pharma Opioids Agonist Drugs Products, Services and Solutions

5.1.4 Purdue Pharma Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.1.5 Purdue Pharma Recent Developments

5.2 Titan pharmaceuticals

5.2.1 Titan pharmaceuticals Profile

5.2.2 Titan pharmaceuticals Main Business

5.2.3 Titan pharmaceuticals Opioids Agonist Drugs Products, Services and Solutions

5.2.4 Titan pharmaceuticals Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.2.5 Titan pharmaceuticals Recent Developments

5.3 Boehringer Ingelheim

5.3.1 Boehringer Ingelheim Profile

5.3.2 Boehringer Ingelheim Main Business

5.3.3 Boehringer Ingelheim Opioids Agonist Drugs Products, Services and Solutions

5.3.4 Boehringer Ingelheim Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.3.5 Janssen Pharmaceuticals, Inc Recent Developments

5.4 Janssen Pharmaceuticals, Inc

5.4.1 Janssen Pharmaceuticals, Inc Profile

5.4.2 Janssen Pharmaceuticals, Inc Main Business

5.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Products, Services and Solutions

5.4.4 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.4.5 Janssen Pharmaceuticals, Inc Recent Developments

5.5 Sanofi

5.5.1 Sanofi Profile

5.5.2 Sanofi Main Business

5.5.3 Sanofi Opioids Agonist Drugs Products, Services and Solutions

5.5.4 Sanofi Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.5.5 Sanofi Recent Developments

5.6 Sun Pharmaceuticals

5.6.1 Sun Pharmaceuticals Profile

5.6.2 Sun Pharmaceuticals Main Business

5.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Products, Services and Solutions

5.6.4 Sun Pharmaceuticals Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.6.5 Sun Pharmaceuticals Recent Developments

5.7 Mallinckrodt Pharmaceuticals

5.7.1 Mallinckrodt Pharmaceuticals Profile

5.7.2 Mallinckrodt Pharmaceuticals Main Business

5.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Products, Services and Solutions

5.7.4 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.7.5 Mallinckrodt Pharmaceuticals Recent Developments

5.8 Egalet Corporation

5.8.1 Egalet Corporation Profile

5.8.2 Egalet Corporation Main Business

5.8.3 Egalet Corporation Opioids Agonist Drugs Products, Services and Solutions

5.8.4 Egalet Corporation Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.8.5 Egalet Corporation Recent Developments

5.9 Endo Pharmaceuticals Inc.

5.9.1 Endo Pharmaceuticals Inc. Profile

5.9.2 Endo Pharmaceuticals Inc. Main Business

5.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Products, Services and Solutions

5.9.4 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.9.5 Endo Pharmaceuticals Inc. Recent Developments

5.10 Allergan, Plc

5.10.1 Allergan, Plc Profile

5.10.2 Allergan, Plc Main Business

5.10.3 Allergan, Plc Opioids Agonist Drugs Products, Services and Solutions

5.10.4 Allergan, Plc Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.10.5 Allergan, Plc Recent Developments

5.11 Pfizer Inc

5.11.1 Pfizer Inc Profile

5.11.2 Pfizer Inc Main Business

5.11.3 Pfizer Inc Opioids Agonist Drugs Products, Services and Solutions

5.11.4 Pfizer Inc Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.11.5 Pfizer Inc Recent Developments

5.12 Johnson & Johnson Services, Inc.

5.12.1 Johnson & Johnson Services, Inc. Profile

5.12.2 Johnson & Johnson Services, Inc. Main Business

5.12.3 Johnson & Johnson Services, Inc. Opioids Agonist Drugs Products, Services and Solutions

5.12.4 Johnson & Johnson Services, Inc. Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.12.5 Johnson & Johnson Services, Inc. Recent Developments

5.13 Hikma Pharmaceuticals PLC

5.13.1 Hikma Pharmaceuticals PLC Profile

5.13.2 Hikma Pharmaceuticals PLC Main Business

5.13.3 Hikma Pharmaceuticals PLC Opioids Agonist Drugs Products, Services and Solutions

5.13.4 Hikma Pharmaceuticals PLC Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.13.5 Hikma Pharmaceuticals PLC Recent Developments

5.14 Grünenthal

5.14.1 Grünenthal Profile

5.14.2 Grünenthal Main Business

5.14.3 Grünenthal Opioids Agonist Drugs Products, Services and Solutions

5.14.4 Grünenthal Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.14.5 Grünenthal Recent Developments

5.15 AbbVie Inc.

5.15.1 AbbVie Inc. Profile

5.15.2 AbbVie Inc. Main Business

5.15.3 AbbVie Inc. Opioids Agonist Drugs Products, Services and Solutions

5.15.4 AbbVie Inc. Opioids Agonist Drugs Revenue (US$ Million) & (2018-2023)

5.15.5 AbbVie Inc. Recent Developments

6 North America

6.1 North America Opioids Agonist Drugs Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Opioids Agonist Drugs Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Opioids Agonist Drugs Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Opioids Agonist Drugs Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Opioids Agonist Drugs Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Opioids Agonist Drugs Market Dynamics

11.1 Opioids Agonist Drugs Industry Trends

11.2 Opioids Agonist Drugs Market Drivers

11.3 Opioids Agonist Drugs Market Challenges

11.4 Opioids Agonist Drugs Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Purdue Pharma

Titan pharmaceuticals

Boehringer Ingelheim

Janssen Pharmaceuticals, Inc.

Sanofi

Sun Pharmaceuticals

Mallinckrodt Pharmaceuticals

Egalet Corporation

Endo Pharmaceuticals Inc

Allergan plc

Pfizer Inc

Johnson & Johnson Services Inc.

Hikma Pharmaceuticals PLC

Grünenthal

AbbVie

List of Tables

Table 1. Global Market Opioids Agonist Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Opioids Agonist Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Opioids Agonist Drugs Market Size Share by Region (2018-2023)

Table 4. Global Opioids Agonist Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Opioids Agonist Drugs Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Opioids Agonist Drugs Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Opioids Agonist Drugs Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Opioids Agonist Drugs Revenue Market Share by Type (2018-2023)

Table 9. Global Opioids Agonist Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Opioids Agonist Drugs Revenue Market Share by Type (2024-2029)

Table 11. North America Opioids Agonist Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Opioids Agonist Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Opioids Agonist Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Opioids Agonist Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Opioids Agonist Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Opioids Agonist Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Opioids Agonist Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Opioids Agonist Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Opioids Agonist Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Opioids Agonist Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Opioids Agonist Drugs Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Opioids Agonist Drugs Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Opioids Agonist Drugs Revenue Market Share by Application (2018-2023)

Table 24. Global Opioids Agonist Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Opioids Agonist Drugs Revenue Market Share by Application (2024-2029)

Table 26. North America Opioids Agonist Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Opioids Agonist Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Opioids Agonist Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Opioids Agonist Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Opioids Agonist Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Opioids Agonist Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Opioids Agonist Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Opioids Agonist Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Opioids Agonist Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Opioids Agonist Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Opioids Agonist Drugs Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Opioids Agonist Drugs Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2022)

Table 39. Date of Key Players Enter into Opioids Agonist Drugs Market

Table 40. Global Opioids Agonist Drugs Key Players Headquarters and Area Served

Table 41. Opioids Agonist Drugs Product Solution and Service

Table 42. Global Opioids Agonist Drugs Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Purdue Pharma Basic Information List

Table 45. Purdue Pharma Description and Business Overview

Table 46. Purdue Pharma Opioids Agonist Drugs Products, Services and Solutions

Table 47. Revenue (US$ Million) in Opioids Agonist Drugs Business of Purdue Pharma (2018-2023)

Table 48. Purdue Pharma Recent Developments

Table 49. Titan pharmaceuticals Basic Information List

Table 50. Titan pharmaceuticals Description and Business Overview

Table 51. Titan pharmaceuticals Opioids Agonist Drugs Products, Services and Solutions

Table 52. Revenue (US$ Million) in Opioids Agonist Drugs Business of Titan pharmaceuticals (2018-2023)

Table 53. Titan pharmaceuticals Recent Developments

Table 54. Boehringer Ingelheim Basic Information List

Table 55. Boehringer Ingelheim Description and Business Overview

Table 56. Boehringer Ingelheim Opioids Agonist Drugs Products, Services and Solutions

Table 57. Revenue (US$ Million) in Opioids Agonist Drugs Business of Boehringer Ingelheim (2018-2023)

Table 58. Boehringer Ingelheim Recent Developments

Table 59. Janssen Pharmaceuticals, Inc Basic Information List

Table 60. Janssen Pharmaceuticals, Inc Description and Business Overview

Table 61. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Products, Services and Solutions

Table 62. Revenue (US$ Million) in Opioids Agonist Drugs Business of Janssen Pharmaceuticals, Inc (2018-2023)

Table 63. Janssen Pharmaceuticals, Inc Recent Developments

Table 64. Sanofi Basic Information List

Table 65. Sanofi Description and Business Overview

Table 66. Sanofi Opioids Agonist Drugs Products, Services and Solutions

Table 67. Revenue (US$ Million) in Opioids Agonist Drugs Business of Sanofi (2018-2023)

Table 68. Sanofi Recent Developments

Table 69. Sun Pharmaceuticals Basic Information List

Table 70. Sun Pharmaceuticals Description and Business Overview

Table 71. Sun Pharmaceuticals Opioids Agonist Drugs Products, Services and Solutions

Table 72. Revenue (US$ Million) in Opioids Agonist Drugs Business of Sun Pharmaceuticals (2018-2023)

Table 73. Sun Pharmaceuticals Recent Developments

Table 74. Mallinckrodt Pharmaceuticals Basic Information List

Table 75. Mallinckrodt Pharmaceuticals Description and Business Overview

Table 76. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Products, Services and Solutions

Table 77. Revenue (US$ Million) in Opioids Agonist Drugs Business of Mallinckrodt Pharmaceuticals (2018-2023)

Table 78. Mallinckrodt Pharmaceuticals Recent Developments

Table 79. Egalet Corporation Basic Information List

Table 80. Egalet Corporation Description and Business Overview

Table 81. Egalet Corporation Opioids Agonist Drugs Products, Services and Solutions

Table 82. Revenue (US$ Million) in Opioids Agonist Drugs Business of Egalet Corporation (2018-2023)

Table 83. Egalet Corporation Recent Developments

Table 84. Endo Pharmaceuticals Inc. Basic Information List

Table 85. Endo Pharmaceuticals Inc. Description and Business Overview

Table 86. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Products, Services and Solutions

Table 87. Revenue (US$ Million) in Opioids Agonist Drugs Business of Endo Pharmaceuticals Inc. (2018-2023)

Table 88. Endo Pharmaceuticals Inc. Recent Developments

Table 89. Allergan, Plc Basic Information List

Table 90. Allergan, Plc Description and Business Overview

Table 91. Allergan, Plc Opioids Agonist Drugs Products, Services and Solutions

Table 92. Revenue (US$ Million) in Opioids Agonist Drugs Business of Allergan, Plc (2018-2023)

Table 93. Allergan, Plc Recent Developments

Table 94. Pfizer Inc Basic Information List

Table 95. Pfizer Inc Description and Business Overview

Table 96. Pfizer Inc Opioids Agonist Drugs Products, Services and Solutions

Table 97. Revenue (US$ Million) in Opioids Agonist Drugs Business of Pfizer Inc (2018-2023)

Table 98. Pfizer Inc Recent Developments

Table 99. Johnson & Johnson Services, Inc. Basic Information List

Table 100. Johnson & Johnson Services, Inc. Description and Business Overview

Table 101. Johnson & Johnson Services, Inc. Opioids Agonist Drugs Products, Services and Solutions

Table 102. Revenue (US$ Million) in Opioids Agonist Drugs Business of Johnson & Johnson Services, Inc. (2018-2023)

Table 103. Johnson & Johnson Services, Inc. Recent Developments

Table 104. Hikma Pharmaceuticals PLC Basic Information List

Table 105. Hikma Pharmaceuticals PLC Description and Business Overview

Table 106. Hikma Pharmaceuticals PLC Opioids Agonist Drugs Products, Services and Solutions

Table 107. Revenue (US$ Million) in Opioids Agonist Drugs Business of Hikma Pharmaceuticals PLC (2018-2023)

Table 108. Hikma Pharmaceuticals PLC Recent Developments

Table 109. Grünenthal Basic Information List

Table 110. Grünenthal Description and Business Overview

Table 111. Grünenthal Opioids Agonist Drugs Products, Services and Solutions

Table 112. Revenue (US$ Million) in Opioids Agonist Drugs Business of Grünenthal (2018-2023)

Table 113. Grünenthal Recent Developments

Table 114. AbbVie Inc. Basic Information List

Table 115. AbbVie Inc. Description and Business Overview

Table 116. AbbVie Inc. Opioids Agonist Drugs Products, Services and Solutions

Table 117. Revenue (US$ Million) in Opioids Agonist Drugs Business of AbbVie Inc. (2018-2023)

Table 118. AbbVie Inc. Recent Developments

Table 119. North America Opioids Agonist Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 120. North America Opioids Agonist Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 121. Europe Opioids Agonist Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 122. Europe Opioids Agonist Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 123. Asia-Pacific Opioids Agonist Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 124. Asia-Pacific Opioids Agonist Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 125. Asia-Pacific Opioids Agonist Drugs Market Size by Region (2024-2029) & (US$ Million)

Table 126. Asia-Pacific Opioids Agonist Drugs Market Share by Region (2018-2023)

Table 127. Asia-Pacific Opioids Agonist Drugs Market Share by Region (2024-2029)

Table 128. Latin America Opioids Agonist Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 129. Latin America Opioids Agonist Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 130. Latin America Opioids Agonist Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 131. Middle East & Africa Opioids Agonist Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 132. Middle East & Africa Opioids Agonist Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 133. Middle East & Africa Opioids Agonist Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 134. Opioids Agonist Drugs Market Trends

Table 135. Opioids Agonist Drugs Market Drivers

Table 136. Opioids Agonist Drugs Market Challenges

Table 137. Opioids Agonist Drugs Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Opioids Agonist Drugs Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Opioids Agonist Drugs Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Opioids Agonist Drugs Market Share by Regions: 2022 VS 2029

Figure 4. Global Opioids Agonist Drugs Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Opioids Agonist Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Opioids Agonist Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Opioids Agonist Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Opioids Agonist Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Opioids Agonist Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Codeine

Figure 11. Global Codeine Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Fentanyl

Figure 13. Global Fentanyl Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Meperidine

Figure 15. Global Meperidine Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Methadone

Figure 17. Global Methadone Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of Morphine

Figure 19. Global Morphine Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Product Picture of Hydrocodone

Figure 21. Global Hydrocodone Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Global Opioids Agonist Drugs Market Size Share by Type: 2022 & 2029

Figure 23. North America Opioids Agonist Drugs Revenue Market Share by Type (2018-2029)

Figure 24. Europe Opioids Agonist Drugs Revenue Market Share by Type (2018-2029)

Figure 25. Asia-Pacific Opioids Agonist Drugs Revenue Market Share by Type (2018-2029)

Figure 26. Latin America Opioids Agonist Drugs Revenue Market Share by Type (2018-2029)

Figure 27. Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Type (2018-2029)

Figure 28. Pain Management Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Cough Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 30. Diarrhea Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 31. Global Opioids Agonist Drugs Market Size Share by Application: 2022 & 2029

Figure 32. North America Opioids Agonist Drugs Revenue Market Share by Application (2018-2029)

Figure 33. Europe Opioids Agonist Drugs Revenue Market Share by Application (2018-2029)

Figure 34. Asia-Pacific Opioids Agonist Drugs Revenue Market Share by Application (2018-2029)

Figure 35. Latin America Opioids Agonist Drugs Revenue Market Share by Application (2018-2029)

Figure 36. Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Application (2018-2029)

Figure 37. Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 38. Global Top 5 and Top 10 Players Opioids Agonist Drugs Market Share in 2022

Figure 39. North America Opioids Agonist Drugs Market Share by Country (2018-2029)

Figure 40. U.S. Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 41. Canada Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 42. Germany Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 43. France Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 44. U.K. Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 45. Italy Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 46. Russia Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 47. Nordic Countries Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 48. Asia-Pacific Opioids Agonist Drugs Market Share by Region (2018-2029)

Figure 49. China Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 50. Japan Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 51. South Korea Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 52. Southeast Asia Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 53. India Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 54. Australia Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 55. Latin America Opioids Agonist Drugs Market Share by Country (2018-2029)

Figure 56. Mexico Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 57. Brazil Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 58. Middle East & Africa Opioids Agonist Drugs Market Share by Country (2018-2029)

Figure 59. Turkey Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 60. Saudi Arabia Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 61. UAE Opioids Agonist Drugs Market Size (2018-2029) & (US$ Million)

Figure 62. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions